Premium
The prevalence of Candida onychomycosis in Southeastern Serbia from 2011 to 2015
Author(s) -
Otašević Suzana,
Barac Aleksandra,
Pekmezovic Marina,
Tasic Sinisa,
Ignjatović Aleksandra,
Momčilović Stefan,
Stojanović Predrag,
Arsic Arsenijevic Valentina,
Hay Roderick
Publication year - 2016
Publication title -
mycoses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 69
eISSN - 1439-0507
pISSN - 0933-7407
DOI - 10.1111/myc.12448
Subject(s) - itraconazole , clotrimazole , fluconazole , medicine , candida albicans , microbiology and biotechnology , candida parapsilosis , candida krusei , dermatology , candida glabrata , antifungal , mycosis , epidemiology , biology , surgery
Summary Despite the increasing of onychomycosis caused by Candida spp., in referent literature, there is still data insufficiency about this nail infection. The objectives of this retrospective study were to determine epidemiological characteristics of Candida onychomycosis, the antifungal susceptibility of isolated species in vitro , and to compare the results of antifungal susceptibility testing with conducted treatment in period from 2011 to the end of March 2015. Out of 761 patients who were underwent clinical and mycological examinations, 137 had Candida species isolated from nails. The dominant species was Candida albicans ( C. albicans ) (36.59%) followed by C. parapsilosis (23.78%), C. krusei (9.76%), and C. guilliermondii (6.71%). Antifungal susceptibility in vitro testing showed good susceptibility to antimycotics, except C. krusei , which was resistance to fluconazole ( FCZ ) and isolates of C. tropicalis and C. glabrata which were dose dependent to itraconazole ( ITZ ) and fluconazole. Evaluation of medical histories determined that combined therapy, which included pulsed systemic regimen of ITZ with topical application of clotrimazole, had better clinical outcomes regarding the proscribed only topical application of clotrimazole. Multidisciplinary approach of dermatologists and mycologists is required in solving the problem of onychomycosis, which is the dominant nail disease.